Unravelling Dendritic Cell Heterogeneity in Health and Disease

Share
Print

Dendritic cells are critical orchestrators of immune responses and represent a key therapeutic target in autoimmunity and cancer. Using single-cell approaches to elucidate dendritic cell heterogeneity, we have identified novel subsets, conserved across mouse and human, with divergent functional phenotypes.  My work addresses the environmental cues that shape lineage specification and the functional role of dendritic cell subsets in tissue homeostasis and disease.

(Refreshments will be served)

Date & Time(s)

Location

Memorial Sloan Kettering Cancer Center
Rockefeller Research Laboratories
430 East 67th Street
Room RRL-116
New York, NY 10065

Contact

For more information, please contact Emily Delgado @ delgadoe@mskcc.org

Sponsor(s)

Human Oncology and Pathogenesis Program

Speaker(s)

Chrysothemis Brown, MBBS, PhD
Post-Doctoral research fellow
Alexander Rudensky Laboratory
Memorial Sloan Kettering Cancer Center
Paediatric Fellow, Institute of Child Health, London, UK